The minister responded negatively to whether there have been an increase in patient deaths due to inadequate beds and fans in hospitals.
There were 1,707 beds and 292 enthusiasts in March who were over 7,403 beds and 906 enthusiasts in September at the country’s thirteen COVID hospitals in the country, Choubey said.
By providing knowledge about the number of pathology laboratories held across the country to conduct COVID-19 tests in response to a question, Choubey said that the Indian Medical Research Council (ICMR), an autonomous organization under the Department of Health Research, reported that as of September 13, a total of 1,717 COVID-19 test laboratories are registered on its portal , comprising 1,049 government laboratories and 668 personal laboratories.
In addition, ICMR has a total of 5,134 antigen sites in its database as of September 17, he said.
“ICMR has reported that as of September thirteen, a total of 5,72,39,428 COVID-19 controls were carried out through the control laboratories, of which 48,46,427 were reported inflamed with COVID-19,” the minister said.
He also stated that ICMR had reported that it was in the process of integrating more new laboratories through its 14 tutoring institutes.
Private and government medical establishments that have yet established a laboratory have been told to speed up the procedure for it. According to ICMR, there are more than 250 laboratories in the procedure for establishing COVID-19 testing facilities, the minister said.
Furthermore, in response to the question, the Minister indicated that India’s screening strategy includes immediate antigen screening for early detection of inflamed COVID-19 patients.
Rapid antibody tests can be used to detect the presence of antibodies in recovered individuals and are used to diagnose patients, he said.
ICMR reported that it had interacted with national brands and expressed interest in providing diagnostics in India. Kit brands must ship their product for validation at ICMR-designated centers.
“Only kits are intended for commercialization through the Comptroller General of Drugs of India. However, kits through the US FDA are not the only ones in the world to do so. But it’s not the first time They are exempt from validation.
“The value acquired is in a tender procedure. The ICMR validation procedure is based on standardized protocols developed in qualified consultations and complies with global standards,” he said.
This story was published from a firm thread without converting the text. Only the name has been changed.
Click here to read that Mint ePapermint is now on Telegram. Join the mint channel in your telegram and informed
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder.